GB0524368D0 - Tetracycline controlled release pharmaceutical composition - Google Patents

Tetracycline controlled release pharmaceutical composition

Info

Publication number
GB0524368D0
GB0524368D0 GBGB0524368.8A GB0524368A GB0524368D0 GB 0524368 D0 GB0524368 D0 GB 0524368D0 GB 0524368 A GB0524368 A GB 0524368A GB 0524368 D0 GB0524368 D0 GB 0524368D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
controlled release
release pharmaceutical
tetracycline controlled
tetracycline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0524368.8A
Other versions
GB2420708A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Accord UK Ltd
Original Assignee
Alpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharma Ltd filed Critical Alpharma Ltd
Publication of GB0524368D0 publication Critical patent/GB0524368D0/en
Publication of GB2420708A publication Critical patent/GB2420708A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
GB0524368A 2003-09-30 2004-09-30 Tetracycline controlled release pharmaceutical composition Withdrawn GB2420708A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0322848A GB0322848D0 (en) 2003-09-30 2003-09-30 Tetracycline controlled release pharmaceutical dosage form
GB0421759A GB2406517B (en) 2003-09-30 2004-09-30 Minocycline controlled release pharmaceutical composition

Publications (2)

Publication Number Publication Date
GB0524368D0 true GB0524368D0 (en) 2006-01-04
GB2420708A GB2420708A (en) 2006-06-07

Family

ID=29287107

Family Applications (3)

Application Number Title Priority Date Filing Date
GB0322848A Ceased GB0322848D0 (en) 2003-09-30 2003-09-30 Tetracycline controlled release pharmaceutical dosage form
GB0421759A Expired - Fee Related GB2406517B (en) 2003-09-30 2004-09-30 Minocycline controlled release pharmaceutical composition
GB0524368A Withdrawn GB2420708A (en) 2003-09-30 2004-09-30 Tetracycline controlled release pharmaceutical composition

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GB0322848A Ceased GB0322848D0 (en) 2003-09-30 2003-09-30 Tetracycline controlled release pharmaceutical dosage form
GB0421759A Expired - Fee Related GB2406517B (en) 2003-09-30 2004-09-30 Minocycline controlled release pharmaceutical composition

Country Status (1)

Country Link
GB (3) GB0322848D0 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US11103517B2 (en) 2015-04-07 2021-08-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3623997A (en) * 1966-06-06 1971-11-30 Ncr Co Wall-sealing treatment for minute capsules and minute capsules having walls of sealed polymeric material
JPS5231981A (en) * 1975-08-18 1977-03-10 Takeda Chem Ind Ltd Microcapsule preparation method
DE69633925T2 (en) * 1995-07-21 2005-11-24 Daiichi Pharmaceutical Co., Ltd. Process for the preparation of a granular preparation
ITMI991316A1 (en) * 1999-06-14 2000-12-14 Cip Ninety Two 92 S A ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF MESALAZINE
US20030021841A1 (en) * 2001-07-02 2003-01-30 Matharu Amol Singh Pharmaceutical composition

Also Published As

Publication number Publication date
GB2406517A (en) 2005-04-06
GB0421759D0 (en) 2004-11-03
GB2420708A (en) 2006-06-07
GB0322848D0 (en) 2003-10-29
GB2406517B (en) 2006-07-12

Similar Documents

Publication Publication Date Title
EP1656115A4 (en) Controlled release compositions
AU2003291103A8 (en) Pharmaceutical composition
TWI319317B (en) Modified release pharmaceutical formulation
EP1607088A4 (en) Controlled release composition
HU0301154D0 (en) Pharmaceutical composition
IL172814A0 (en) Novel solid pharmaceutical composition comprising amisulpride
HK1089697A1 (en) Modafinil modified release pharmaceutical compositions
GB0300427D0 (en) Pharmaceutical composition
AU2003260803A8 (en) Sustained release pharmaceutical composition
AU2003250372A8 (en) Pharmaceutical composition
EP1411904A4 (en) Sustained release pharmaceutical composition
EP1753405A4 (en) Controlled release pharmaceutical formulation
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
PL376840A1 (en) Prolonged release pharmaceutical composition
IL165069A0 (en) Immediate release pharmaceutical formulation
GB0317663D0 (en) Pharmaceutical composition
HK1093896A1 (en) Medicinal composition
EP1478353A4 (en) Sustained release pharmaceutical composition
GB0300885D0 (en) Pharmaceutical composition
EP1600445A4 (en) Medicinal composition
GB0421759D0 (en) Tetracycline controlled release pharmaceutical composition
GB0306933D0 (en) Pharmaceutical composition
GB0307869D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)